We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Can Cell Cycle Protein Prevent or Kill Breast Cancer Tumors?

Can Cell Cycle Protein Prevent or Kill Breast Cancer Tumors?

Can Cell Cycle Protein Prevent or Kill Breast Cancer Tumors?

Can Cell Cycle Protein Prevent or Kill Breast Cancer Tumors?

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Can Cell Cycle Protein Prevent or Kill Breast Cancer Tumors?"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Every parent knows the maxim “feed a cold, starve a fever.” In cancer, however, exactly how to feed or starve a tumor has not been easy to determine.

A study led by scientists at The University of Texas MD Anderson Cancer Centerhas shown that a simple molecule called 14-3-3 sigma could be one answer for explaining cancer metabolism, the chemical process by which a tumor forms, grows or dies. 


 “We know that all cancers grow by learning how to reprogram their metabolism,” said Mong-Hong Lee, Ph.D., professor of Molecular and Cellular Oncology. “But exactly how this occurs has not been fully understood. Our study showed that 14-3-3 sigma opposes and reverses tumor-promoting metabolic programs.” 

Lee’s study results revealed new understanding about how 14-3-3 sigma – a cell cycle “controller” –regulates cancer metabolic programming, thus protecting healthy cells from turning into tumor-producing factories.

In vivo and in vitro experiments showed that, among many biochemical effects, 14-3-3 sigma suppresses cancer glycosis, which prevents cancer’s ability to convert glucose into pyruvate, a substance essential for cell growth.

“14-3-3 sigma expression levels can help predict overall and recurrence-free survival rates, tumor glucose uptake, and metabolic gene expression in breast cancer patients,” said Lee. “These results highlight that 14-3-3 sigma is an important regulator of tumor metabolism, and loss of 14-3-3 sigma expression is critical for cancer metabolic reprogramming.”

Lee believes that the study findings provide additional insight about the “crosstalk” between cancer metabolism and cell cycle.

“We anticipate that pharmacologically elevating 14-3-3 sigma’s function in tumors could be a promising direction for targeted anti-cancer metabolism therapy development in the future,” he said.